Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2003
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003EP0702793B1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation
08/27/2003EP0667910B1 A bacillus promoter derived from a variant of a bacillus licheniformis alpha-amylase promoter
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/27/2003CN1439017A Novel compounds
08/27/2003CN1438317A Method for producing purposive protein using homologous recombination method to obtain transgenosis tussah
08/27/2003CN1438240A Method for preparing phycocyanin of sea water
08/27/2003CN1438233A Tomato 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer
08/27/2003CN1437957A Method for producing whole silkworm powder milk-containing and ferritin
08/27/2003CN1437864A Process of making high-concentration waste liquid of aginomoto convert into fodder protein
08/27/2003CN1119421C Recombinant fusion proteins to growth hormone and serum albumin
08/27/2003CN1119170C Use of micrococcin antibiotics for the preparation of pharmaceuticals for treating or preventing mastitis
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/26/2003USRE38240 DNA encoding human endothelial cell growth factors and plasmids comprising said DNA
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610536 Nucleic acids and polypeptides
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610526 Human E1-like protein
08/26/2003US6610517 Compartmentalization of recombinant polypeptides in host cells
08/26/2003US6610516 A glycoprotein is produced by a process comprising culturing mammalian host cells expressing nucleic acid encoding a glycoprotein in the presence of (a) a factor that modifies growth state in a cell culture, (b) a divalent metal cation or
08/26/2003US6610513 Receptor proteins
08/26/2003US6610511 Drosophila odorant receptors
08/26/2003US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be
08/26/2003US6610507 Polynucleotides encoding patched proteins
08/26/2003US6610493 Screening compounds for the ability to alter the production of amyloid-β peptide
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610477 Human DNA mismatch repair proteins
08/26/2003US6610476 Nucleotide sequence of HTLV-III DNA; identification, isolation and expression of HTLV-III sequences which encode immunoreactive polypeptides by recombinant,DNA methods and production of viral RNA are disclosed. Such polypeptides can
08/26/2003US6610334 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins
08/26/2003US6610307 Immunity against pasteurella haemolytica leukotoxin
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/26/2003US6610285 A full-length cDNA corresponding to an EST (AA418955), which does not show any homology to other proteins in the database but has a weak homology to G-CSF, has been successfully isolated by synthesizing primers based on the EST sequence,
08/26/2003CA2277896C Preparation of collagen
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/21/2003WO2003069337A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
08/21/2003WO2003069330A1 System and method for identifying proteins involved in force-initiated signal transduction
08/21/2003WO2003068993A1 Method for isolation and purification of expressed gene products in vitro
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068956A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003WO2003068948A1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003WO2003068940A2 Complexes and methods of using same
08/21/2003WO2003068933A2 Optimization of gene sequences of virus-like particles for expression in insect cells
08/21/2003WO2003068926A2 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068915A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068804A2 Novel insect cell line
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068802A2 Materials and methods for preparing dimeric growth factors
08/21/2003WO2003068799A2 Oligomeric molecules and uses thereof
08/21/2003WO2003068735A2 Use of xylene monooxygenase for the oxidation of substituted polycyclic aromatic compounds
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068163A2 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003054014A3 Apolipoprotein biopolymer markers predictive of alzheimers disease
08/21/2003WO2003046138A3 Genetically stable expression vector
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003040394A3 Production of recombinant proteins in vivo and use for generating antibodies
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003029425A3 Whole cell engineering using real-time metabolic flux analysis
08/21/2003WO2003027300A3 Use of aminoglycoside resistance gene
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003016471A3 Periostin-based diagnostic assays
08/21/2003WO2003002609A3 Dual-specific ligand and its use
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002061090A3 Prokaryotically produced antibodies and uses thereof
08/21/2003WO2002048405A3 Non-invasive method for detecting target rna
08/21/2003WO2002047613A3 Immunogenic cancer peptides and uses thereof
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002029083A3 Industrial-scale serum-free production of recombinant proteins in mammalian cells
08/21/2003WO2002012284A3 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2002008453A3 Canine toxicity genes
08/21/2003WO2001085792A3 Mu-1, member of the cytokine receptor family
08/21/2003US20030159179 Genetic engineered transgenic plant; controlling,germination
08/21/2003US20030159166 Collecting antibodies from immunized mouse
08/21/2003US20030158398 Central nervous system disorders; psychological disorders
08/21/2003US20030158391 Anitbodies and method for producing same, the use thereof and immunisation cocktails, immunoassays-sets and peptides
08/21/2003US20030158389 Immunoglobulins; genetic engineering
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158379 A DNA molecules encoding the proteins, used in the treatment of bone, connective tissue, tendon, ligament, wound healing and defects to tissues, animal growth factors, cell differentiation of embryonic and stem cells
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158141 Comprising virus, non-coding regulatory region of which is replaced by heterologous encoding sequence, wherein function of replaced regulatory region is dependent upon secondary structure and wherein encoding sequence has said function
08/21/2003US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample
08/21/2003US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 ... 1125